>
Innovus Pharmaceuticals Inc logo

INNV - Innovus Pharmaceuticals Inc Share Price

$1.23 0.1  6.0%

Last Trade - 14/02/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £16.4m
Position in Universe th / 6847
Bullish
Bearish
Unlock INNV Revenue
Momentum
Relative Strength (%)
1m +39.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
0.007 1.03 0.74 4.82 8.82 24.0 26.3 40.5 +414.7%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2019, InnovusPharmaceuticals Inc revenues decreased 7% to $18M. Net lossdecreased 2% to $6M. Revenues reflect Product salesdecrease of 6% to $17.4M, Service revenue decrease of 55%to $156K, Cooperative marketing revenue decrease of 37% to$264K. Lower net loss reflects Sales and marketing decreaseof 41% to $8.3M (expense), LOSS ON EXTINGUISHMENT OF DEBTdecrease of 88% to $125K (expense), Other income (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

INNV Revenue Unlock INNV Revenue

Net Income

INNV Net Income Unlock INNV Revenue

Normalised EPS

INNV Normalised EPS Unlock INNV Revenue

PE Ratio Range

INNV PE Ratio Range Unlock INNV Revenue

Dividend Yield Range

INNV Dividend Yield Range Unlock INNV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
INNV EPS Forecasts Unlock INNV Revenue
Profile Summary

Innovus Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the commercialization, licensing, and development of non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases. The Company markets approximately 28 products in the United States and with 12 of those being marketed and sold in multiple countries around the world through some of our 18 international commercial partners. Its products include Vesele, Zestra, Zestra Glide, EjectDelay, Sensum+, Beyond Human, RecalMax, Beyond Human Omega 3 Fish Oil, Beyond Human Eagle Vision Formula, Beyond Human Blood Sugar, Beyond Human Colon Cleanse, Beyond Human Green Coffee ,Beyond Human Growth Agent, RecalMax for brain health, Androferti, UriVarx, PEVarx, ProstaGorx, FlutiCare, Apeaz, AllerVarx, ArthriVarx, Xyralid, Can-C Eye Drops, Can-C capsules, MZS, and Diabasens.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated July 23, 2007
Public Since September 25, 2006
No. of Shareholders: n/a
No. of Employees: 1
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OTC Markets Group
Shares in Issue 3,204,401
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
INNV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for INNV
Upcoming Events for INNV
Frequently Asked Questions for Innovus Pharmaceuticals Inc
What is the Innovus Pharmaceuticals Inc share price?

As of 14/02/20, shares in Innovus Pharmaceuticals Inc are trading at $1.23, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Innovus Pharmaceuticals Inc share price performed this year?

Shares in Innovus Pharmaceuticals Inc are currently trading at $1.23 and the price has moved by -76.57% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Innovus Pharmaceuticals Inc price has moved by -84.23% over the past year.

What are the analyst and broker recommendations for Innovus Pharmaceuticals Inc?

Of the analysts with advisory recommendations for Innovus Pharmaceuticals Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Innovus Pharmaceuticals Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Innovus Pharmaceuticals Inc next release its financial results?

Innovus Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Innovus Pharmaceuticals Inc dividend yield?

Innovus Pharmaceuticals Inc does not currently pay a dividend.

Does Innovus Pharmaceuticals Inc pay a dividend?

Innovus Pharmaceuticals Inc does not currently pay a dividend.

When does Innovus Pharmaceuticals Inc next pay dividends?

Innovus Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Innovus Pharmaceuticals Inc shares?

To buy shares in Innovus Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Innovus Pharmaceuticals Inc?

Shares in Innovus Pharmaceuticals Inc are currently trading at $1.23, giving the company a market capitalisation of £n/a.

Where are Innovus Pharmaceuticals Inc shares listed? Where are Innovus Pharmaceuticals Inc shares listed?

Here are the trading details for Innovus Pharmaceuticals Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: INNV
What kind of share is Innovus Pharmaceuticals Inc?

We were not able to load our ranking data for Innovus Pharmaceuticals Inc

Is there a Innovus Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Innovus Pharmaceuticals Inc.

How can I tell whether the Innovus Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovus Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been -44.21%. At the current price of $1.23, shares in Innovus Pharmaceuticals Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Innovus Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for Innovus Pharmaceuticals Inc.

Who are the key directors of Innovus Pharmaceuticals Inc?

We were unable to find the directors for Innovus Pharmaceuticals Inc.

Who are the major shareholders of Innovus Pharmaceuticals Inc?

Here are the top five shareholders of Innovus Pharmaceuticals Inc based on the size of their shareholding:

Armistice Capital LLC Hedge Fund
Percentage owned: 9.36% (300k shares)
LGH Investments, LLC Corporation
Percentage owned: 8.58% (275k shares)
Novalere Holdings, L.L.C. Corporation
Percentage owned: 7.61% (244k shares)
Damaj (Bassam B) Individual Investor
Percentage owned: 5.89% (189k shares)
Liu (Vivian H) Individual Investor
Percentage owned: 0.25% (8.05k shares)
Similar to INNV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.